Search Results (54)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Tumor Escape | Concept |
Why?
|
| Kohler, Mark | Person |
Why?
|
| The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC. | Academic Article |
Why?
|
| Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression. | Academic Article |
Why?
|
| C reactive protein impairs adaptive immunity in immune cells of patients with melanoma. | Academic Article |
Why?
|
| Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. | Academic Article |
Why?
|
| Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1. | Academic Article |
Why?
|
| Multi-Specific CAR Targeting to Prevent Antigen Escape. | Academic Article |
Why?
|
| McCarter, Martin | Person |
Why?
|
| Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. | Academic Article |
Why?
|
| Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. | Academic Article |
Why?
|
| The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients. | Academic Article |
Why?
|
| Fry, Terry | Person |
Why?
|
| Torres, Raul | Person |
Why?
|
| Slansky, Jill | Person |
Why?
|